Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

robot
Abstract generation in progress

Agilent Technologies Inc. announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution. This new entity integrates the company’s capabilities in Canada (BIOVECTRA) and the United States (Nucleic Acid Solutions) to offer a comprehensive suite of manufacturing services. The initiative aims to provide customers with streamlined access to end-to-end development and manufacturing services for advanced therapies from a single partner.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin